Kanes Stephen 4
4 · Sage Therapeutics, Inc. · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-04-02+27,000→ 27,000 totalExercise: $145.77Exp: 2028-04-02→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The securities awarded on 4/2/2018 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 3,375 shares of common stock shall vest on the one year anniversary of the 2/1/2018 Vesting Start Date with 10,125 shares vesting in 36 equal monthly installments thereafter. Options to purchase 13,500 shares of common stock shall vest periodically upon the Company achieving certain milestones.